Gain Therapeutics, Inc. (GANX)
3.15
-0.07
(-2.17%)
USD |
NASDAQ |
Dec 26, 16:00
3.14
-0.01
(-0.32%)
After-Hours: 20:00
Gain Therapeutics Market Cap: 114.16M for Dec. 26, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 14.29M |
| AIM ImmunoTech, Inc. | 0.9553M |
| IGC Pharma, Inc. | 27.85M |
| NovaBay Pharmaceuticals, Inc. | 611.15M |
| Protalix Biotherapeutics, Inc. | 145.56M |
Market Cap Related Metrics
| Price to Book Value | 19.32 |
| Price | 3.15 |
| Earnings Yield | -20.30% |